Capitol Hill House committee issues subpoena for NIH’s Monica Bertagnolli to address NIH sexual misconduct policies February 09, 2024Vol.50 No.06By Matthew Bin Han Ong
Conversation with The Cancer Letter Shikha Jain, Shea Holman: It’s time for NIH to be transparent about how misconduct cases are handled February 09, 2024Vol.50 No.06By Matthew Bin Han Ong
Conversation with The Cancer Letter Ellen Sigal, Roy Herbst: Friends and FDA to focus on real-world evidence, AI, and streamlined trials in 2024 February 09, 2024Vol.50 No.06By Paul Goldberg and Matthew Bin Han Ong
Trials & Tribulations Florez Laboratory at Dana-Farber launches International Pregnancy and Lung Cancer Registry February 09, 2024Vol.50 No.06By Narjust Florez, Lauren Keil, Rebekah Kaufman and Oyepeju Abioye-Akintola
Impact factor mania and publish-or-perish may have contributed to Dana-Farber retractions, experts sayLearning from past errors (and misconduct) in cancer research February 02, 2024Vol.50 No.05By Jacquelyn Cobb
Regulatory News FDA tells sponsors of CAR T-cell therapies to add boxed warning about secondary T-cell malignancies February 02, 2024Vol.50 No.05By Alexandria Carolan
Black History Month Video series uses storytelling to increase diversity in clinical trials: “Having a seat at the table is essential” February 02, 2024Vol.50 No.05
NCI Outstanding Investigator Award (with up to $600,000 a year) goes to 17 scientists February 02, 2024Vol.50 No.05By Jacquelyn Cobb
FreeIn the Archives Past Black History Month coverage from guest editor Robert A. Winn February 02, 2024Vol.50 No.05
FreeObituary Edith Mitchell, medical oncologist, champion of health equity, and brigadier general, dies at 76 January 26, 2024Vol.50 No.04By Alexandria Carolan
